Literature DB >> 15621562

Molecular mimicry to Borrelia burgdorferi: pathway to autoimmunity?

Devin D Bolz1, Janis J Weis.   

Abstract

Lyme borreliosis is due to infection with the tick-borne spirochete Borrelia burgdorferi, and is associated with persistent infection unless treated with antibiotics. The persistent nature of infection by B. burgdorferi can lead to development of chronic disease, as found in patients infected before recognition of the effectiveness of antibiotic therapy. Much speculation has surrounded the possibility that autoimmune mechanisms are involved in chronic symptoms. In most cases, involvement of autoimmunity in Lyme disease has not received experimental support. The exception is in a small group of patients with chronic arthritis whose abnormal joint symptoms persist after apparent elimination of the bacteria. In this review, the evidence supporting autoimmune mechanisms in Lyme disease will be discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15621562     DOI: 10.1080/08916930410001713098

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  9 in total

1.  Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms.

Authors:  Abhishek Chandra; Gary P Wormser; Mark S Klempner; Richard P Trevino; Mary K Crow; Norman Latov; Armin Alaedini
Journal:  Brain Behav Immun       Date:  2010-03-18       Impact factor: 7.217

Review 2.  MyD88 in Mycobacterium tuberculosis infection.

Authors:  Jorge L Cervantes
Journal:  Med Microbiol Immunol       Date:  2017-02-20       Impact factor: 3.402

3.  CC chemokine receptor (CCR)-2 prevents arthritis development following infection by Mycobacterium avium.

Authors:  Marlon P Quinones; Fabio Jimenez; Hernan Martinez; Carlos A Estrada; Opal Willmon; Molly Dudley; William A Kuziel; Peter C Melby; Robert L Reddick; Sunil K Ahuja; Seema S Ahuja
Journal:  J Mol Med (Berl)       Date:  2006-03-07       Impact factor: 4.599

4.  Differential diagnoses of suspected Lyme borreliosis or post-Lyme-disease syndrome.

Authors:  M F Seidel; A Belda Domene; H Vetter
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-09       Impact factor: 3.267

5.  Lyme Disease in Humans.

Authors:  Justin D Radolf; Klemen Strle; Jacob E Lemieux; Franc Strle
Journal:  Curr Issues Mol Biol       Date:  2020-12-11       Impact factor: 2.081

6.  Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection.

Authors:  Monica E Embers; Stephen W Barthold; Juan T Borda; Lisa Bowers; Lara Doyle; Emir Hodzic; Mary B Jacobs; Nicole R Hasenkampf; Dale S Martin; Sukanya Narasimhan; Kathrine M Phillippi-Falkenstein; Jeanette E Purcell; Marion S Ratterree; Mario T Philipp
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

7.  Neuropathogenicity of non-viable Borrelia burgdorferi ex vivo.

Authors:  Geetha Parthasarathy; Shiva Kumar Goud Gadila
Journal:  Sci Rep       Date:  2022-01-13       Impact factor: 4.996

8.  Peptidylarginine Deiminase 2 Autoantibodies Are Linked to Less Severe Disease in Multiple Sclerosis and Post-treatment Lyme Disease.

Authors:  Yaewon Kim; Alison W Rebman; Tory P Johnson; Hong Wang; Ting Yang; Carlo Colantuoni; Pavan Bhargava; Michael Levy; Peter A Calabresi; John N Aucott; Mark J Soloski; Erika Darrah
Journal:  Front Neurol       Date:  2022-06-06       Impact factor: 4.086

9.  Late Disseminated Lyme Disease: Associated Pathology and Spirochete Persistence Posttreatment in Rhesus Macaques.

Authors:  Nicholas A Crossland; Xavier Alvarez; Monica E Embers
Journal:  Am J Pathol       Date:  2017-12-12       Impact factor: 4.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.